

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of skeletal muscle contraction (GO:0014819) | 8.45775208 |
| 2 | muscle filament sliding (GO:0030049) | 8.38855966 |
| 3 | actin-myosin filament sliding (GO:0033275) | 8.38855966 |
| 4 | skeletal muscle contraction (GO:0003009) | 8.36877478 |
| 5 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 7.56633577 |
| 6 | actin-mediated cell contraction (GO:0070252) | 7.20783038 |
| 7 | skeletal muscle adaptation (GO:0043501) | 6.60540214 |
| 8 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 6.26375469 |
| 9 | skeletal muscle fiber development (GO:0048741) | 6.17959821 |
| 10 | cardiac myofibril assembly (GO:0055003) | 5.83398156 |
| 11 | myotube cell development (GO:0014904) | 5.54932935 |
| 12 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 5.50682080 |
| 13 | actin filament-based movement (GO:0030048) | 5.32434016 |
| 14 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 5.06582072 |
| 15 | positive regulation of myotube differentiation (GO:0010831) | 4.90981452 |
| 16 | neuronal action potential propagation (GO:0019227) | 4.83741184 |
| 17 | striated muscle contraction (GO:0006941) | 4.81924449 |
| 18 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 4.80889799 |
| 19 | glycogen catabolic process (GO:0005980) | 4.60887977 |
| 20 | regulation of cell communication by electrical coupling (GO:0010649) | 4.56831361 |
| 21 | NADH metabolic process (GO:0006734) | 4.44704149 |
| 22 | response to inactivity (GO:0014854) | 4.43578934 |
| 23 | striated muscle atrophy (GO:0014891) | 4.40554179 |
| 24 | glucan catabolic process (GO:0009251) | 4.33354764 |
| 25 | fructose metabolic process (GO:0006000) | 4.29885642 |
| 26 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 4.28539804 |
| 27 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 4.25340977 |
| 28 | muscle atrophy (GO:0014889) | 4.25331589 |
| 29 | sarcomere organization (GO:0045214) | 4.25124232 |
| 30 | plasma membrane repair (GO:0001778) | 4.22454829 |
| 31 | myofibril assembly (GO:0030239) | 4.22388151 |
| 32 | creatine metabolic process (GO:0006600) | 4.20867300 |
| 33 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 4.17305435 |
| 34 | cardiac muscle hypertrophy (GO:0003300) | 4.13203067 |
| 35 | response to activity (GO:0014823) | 4.12095126 |
| 36 | muscle tissue morphogenesis (GO:0060415) | 4.02787143 |
| 37 | response to muscle activity (GO:0014850) | 4.01342754 |
| 38 | heart contraction (GO:0060047) | 4.00396130 |
| 39 | heart process (GO:0003015) | 4.00396130 |
| 40 | negative regulation of muscle hypertrophy (GO:0014741) | 3.97584970 |
| 41 | cellular polysaccharide catabolic process (GO:0044247) | 3.97335051 |
| 42 | striated muscle hypertrophy (GO:0014897) | 3.94038180 |
| 43 | muscle contraction (GO:0006936) | 3.91118890 |
| 44 | polysaccharide catabolic process (GO:0000272) | 3.83544257 |
| 45 | muscle organ morphogenesis (GO:0048644) | 3.82565577 |
| 46 | skeletal muscle tissue regeneration (GO:0043403) | 3.76733744 |
| 47 | gluconeogenesis (GO:0006094) | 3.75439071 |
| 48 | cardiac muscle tissue morphogenesis (GO:0055008) | 3.75058760 |
| 49 | neuromuscular synaptic transmission (GO:0007274) | 3.73203242 |
| 50 | striated muscle tissue development (GO:0014706) | 3.68251915 |
| 51 | striated muscle adaptation (GO:0014888) | 3.67154303 |
| 52 | positive regulation of myoblast differentiation (GO:0045663) | 3.64974937 |
| 53 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 3.64581235 |
| 54 | muscle fiber development (GO:0048747) | 3.64557601 |
| 55 | * glycogen metabolic process (GO:0005977) | 3.61170785 |
| 56 | * cellular glucan metabolic process (GO:0006073) | 3.53921154 |
| 57 | * glucan metabolic process (GO:0044042) | 3.53921154 |
| 58 | muscle system process (GO:0003012) | 3.53371394 |
| 59 | 2-oxoglutarate metabolic process (GO:0006103) | 3.51496900 |
| 60 | muscle hypertrophy (GO:0014896) | 3.50820076 |
| 61 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.47414460 |
| 62 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.47414460 |
| 63 | carnitine shuttle (GO:0006853) | 3.44096534 |
| 64 | cardiac muscle cell development (GO:0055013) | 3.41706844 |
| 65 | muscle cell development (GO:0055001) | 3.40730318 |
| 66 | hexose biosynthetic process (GO:0019319) | 3.40008870 |
| 67 | muscle structure development (GO:0061061) | 3.36541842 |
| 68 | muscle organ development (GO:0007517) | 3.33475861 |
| 69 | regulation of muscle system process (GO:0090257) | 3.32693268 |
| 70 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.30055046 |
| 71 | adult heart development (GO:0007512) | 3.29830445 |
| 72 | negative regulation of muscle contraction (GO:0045932) | 3.28939533 |
| 73 | IMP metabolic process (GO:0046040) | 3.28024568 |
| 74 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.25024405 |
| 75 | tricarboxylic acid cycle (GO:0006099) | 3.22800499 |
| 76 | negative regulation of skeletal muscle tissue development (GO:0048642) | 3.21898012 |
| 77 | central nervous system myelination (GO:0022010) | 3.17167862 |
| 78 | axon ensheathment in central nervous system (GO:0032291) | 3.17167862 |
| 79 | myoblast fusion (GO:0007520) | 3.15852392 |
| 80 | regulation of striated muscle contraction (GO:0006942) | 3.14214894 |
| 81 | negative regulation of protein localization to cell surface (GO:2000009) | 3.12887038 |
| 82 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.10691244 |
| 83 | muscle adaptation (GO:0043500) | 3.07638211 |
| 84 | actomyosin structure organization (GO:0031032) | 3.06832397 |
| 85 | limb bud formation (GO:0060174) | 3.04374330 |
| 86 | calcium ion import (GO:0070509) | 2.99966344 |
| 87 | muscle cell fate commitment (GO:0042693) | 2.93880064 |
| 88 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.92101435 |
| 89 | regulation of actin filament-based movement (GO:1903115) | 2.91904350 |
| 90 | regulation of myoblast differentiation (GO:0045661) | 2.90564462 |
| 91 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.87334689 |
| 92 | skeletal muscle tissue development (GO:0007519) | 2.85232596 |
| 93 | otic vesicle formation (GO:0030916) | 2.84397034 |
| 94 | muscle cell cellular homeostasis (GO:0046716) | 2.80537649 |
| 95 | cytidine deamination (GO:0009972) | 2.78622551 |
| 96 | cytidine metabolic process (GO:0046087) | 2.78622551 |
| 97 | cytidine catabolic process (GO:0006216) | 2.78622551 |
| 98 | cellular response to epinephrine stimulus (GO:0071872) | 2.75279192 |
| 99 | myotube differentiation (GO:0014902) | 2.74497224 |
| 100 | import into cell (GO:0098657) | 2.74424787 |
| 101 | regulation of sarcomere organization (GO:0060297) | 2.73097757 |
| 102 | neuromuscular junction development (GO:0007528) | 2.72607509 |
| 103 | response to epinephrine (GO:0071871) | 2.71029041 |
| 104 | positive regulation of protein kinase C signaling (GO:0090037) | 2.70764521 |
| 105 | fatty acid transmembrane transport (GO:1902001) | 2.70682827 |
| 106 | cellular carbohydrate catabolic process (GO:0044275) | 2.69969903 |
| 107 | negative regulation of cardiac muscle hypertrophy (GO:0010614) | 2.67849674 |
| 108 | syncytium formation by plasma membrane fusion (GO:0000768) | 2.64159013 |
| 109 | regulation of skeletal muscle cell differentiation (GO:2001014) | 2.63680997 |
| 110 | neuron fate determination (GO:0048664) | 2.63417022 |
| 111 | negative regulation of cAMP-mediated signaling (GO:0043951) | 2.62918025 |
| 112 | cardiac muscle contraction (GO:0060048) | 2.62128786 |
| 113 | regulation of membrane repolarization (GO:0060306) | 2.61138982 |
| 114 | * glucan biosynthetic process (GO:0009250) | 2.60776259 |
| 115 | * glycogen biosynthetic process (GO:0005978) | 2.60776259 |
| 116 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.58848984 |
| 117 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.58848984 |
| 118 | regulation of relaxation of muscle (GO:1901077) | 2.57889205 |
| 119 | presynaptic membrane assembly (GO:0097105) | 2.56708700 |
| 120 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.54221720 |
| 121 | postsynaptic membrane organization (GO:0001941) | 2.54115393 |
| 122 | striated muscle cell development (GO:0055002) | 2.54059707 |
| 123 | cranial nerve morphogenesis (GO:0021602) | 2.53233696 |
| 124 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.52173903 |
| 125 | positive regulation of action potential (GO:0045760) | 2.52171957 |
| 126 | presynaptic membrane organization (GO:0097090) | 2.51767780 |
| 127 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.51307466 |
| 128 | regulation of muscle contraction (GO:0006937) | 2.49178424 |
| 129 | carnitine transmembrane transport (GO:1902603) | 2.48841707 |
| 130 | long-chain fatty acid biosynthetic process (GO:0042759) | 2.47736836 |
| 131 | membrane depolarization during action potential (GO:0086010) | 2.47560536 |
| 132 | syncytium formation (GO:0006949) | 2.47191701 |
| 133 | respiratory electron transport chain (GO:0022904) | 2.46306036 |
| 134 | positive regulation of inositol phosphate biosynthetic process (GO:0060732) | 2.44165207 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.28152581 |
| 2 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.73865697 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.65339400 |
| 4 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.98231636 |
| 5 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 2.93549476 |
| 6 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 2.93549476 |
| 7 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.63170323 |
| 8 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.58195333 |
| 9 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.57069632 |
| 10 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.44860871 |
| 11 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.42085731 |
| 12 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.39864852 |
| 13 | VDR_22108803_ChIP-Seq_LS180_Human | 2.36235291 |
| 14 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.33359877 |
| 15 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.32112801 |
| 16 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 2.26318367 |
| 17 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.16532690 |
| 18 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.16532690 |
| 19 | * MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 2.14863040 |
| 20 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.14531114 |
| 21 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.13049113 |
| 22 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 2.10734706 |
| 23 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.05408347 |
| 24 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.02962172 |
| 25 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.02747083 |
| 26 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.99333972 |
| 27 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.96503142 |
| 28 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.95021980 |
| 29 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.90990294 |
| 30 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.90657319 |
| 31 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.86126849 |
| 32 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.85216910 |
| 33 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.82869270 |
| 34 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.79713430 |
| 35 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.76884986 |
| 36 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.74347469 |
| 37 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.72992021 |
| 38 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.71197776 |
| 39 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.71137150 |
| 40 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.65128093 |
| 41 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.61977601 |
| 42 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.61172034 |
| 43 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.60509070 |
| 44 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.58163075 |
| 45 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.55681983 |
| 46 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.54781988 |
| 47 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.53985237 |
| 48 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.52120452 |
| 49 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.50656348 |
| 50 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.50526841 |
| 51 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.48290264 |
| 52 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.48266025 |
| 53 | GATA1_22025678_ChIP-Seq_K562_Human | 1.46948412 |
| 54 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.42919369 |
| 55 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.42755226 |
| 56 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.42155301 |
| 57 | P300_19829295_ChIP-Seq_ESCs_Human | 1.42014363 |
| 58 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.41127702 |
| 59 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.39708129 |
| 60 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.39619568 |
| 61 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.38979780 |
| 62 | * SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.37957120 |
| 63 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.37729846 |
| 64 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.37619462 |
| 65 | FUS_26573619_Chip-Seq_HEK293_Human | 1.33139621 |
| 66 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.32965115 |
| 67 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.32181340 |
| 68 | * PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.32025329 |
| 69 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.29752831 |
| 70 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.29468238 |
| 71 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.29253149 |
| 72 | * SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.28431129 |
| 73 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.27925907 |
| 74 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.27076619 |
| 75 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.27033762 |
| 76 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.26819799 |
| 77 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.26375022 |
| 78 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.26289062 |
| 79 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.25954357 |
| 80 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.25377178 |
| 81 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.23679630 |
| 82 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.21789317 |
| 83 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.21115197 |
| 84 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.20171160 |
| 85 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.20069668 |
| 86 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.19711191 |
| 87 | * EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.16923829 |
| 88 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.16312215 |
| 89 | * NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.16222594 |
| 90 | * EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.16122825 |
| 91 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.15357202 |
| 92 | SA1_27219007_Chip-Seq_Bcells_Human | 1.11692694 |
| 93 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11123643 |
| 94 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.11102432 |
| 95 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.10821495 |
| 96 | * P53_22387025_ChIP-Seq_ESCs_Mouse | 1.10339360 |
| 97 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.10197181 |
| 98 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.09329902 |
| 99 | TP53_16413492_ChIP-PET_HCT116_Human | 1.09025315 |
| 100 | * EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.08990951 |
| 101 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.08777493 |
| 102 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.08703541 |
| 103 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.08633964 |
| 104 | * SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.08353552 |
| 105 | AR_25329375_ChIP-Seq_VCAP_Human | 1.07842104 |
| 106 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.07647728 |
| 107 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.07647728 |
| 108 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.07594835 |
| 109 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.07294283 |
| 110 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 1.05929864 |
| 111 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 1.05923771 |
| 112 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.05753310 |
| 113 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.04999600 |
| 114 | * OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.04255054 |
| 115 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.04115915 |
| 116 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.03901465 |
| 117 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.02748776 |
| 118 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.02743726 |
| 119 | STAT3_23295773_ChIP-Seq_U87_Human | 1.02713899 |
| 120 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.02577135 |
| 121 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.02528167 |
| 122 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.02407086 |
| 123 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.01180420 |
| 124 | * RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.00676008 |
| 125 | KDM2B_26808549_Chip-Seq_REH_Human | 1.00617900 |
| 126 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.99780718 |
| 127 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.99521072 |
| 128 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.99406961 |
| 129 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.99406961 |
| 130 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.99350342 |
| 131 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.98420385 |
| 132 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.97934174 |
| 133 | * STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.97352044 |
| 134 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.96493696 |
| 135 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.96354192 |
| 136 | * P300_18555785_Chip-Seq_ESCs_Mouse | 0.96091613 |
| 137 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.95702164 |
| 138 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.95251338 |
| 139 | * SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.94761354 |
| 140 | * CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.94459729 |
| 141 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.94296306 |
| 142 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.94210334 |
| 143 | TCF4_23295773_ChIP-Seq_U87_Human | 0.93771616 |
| 144 | * OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.93667203 |
| 145 | * NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.93593552 |
| 146 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.91410645 |
| 147 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.91282954 |
| 148 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.89767804 |
| 149 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.89200253 |
| 150 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.88320724 |
| 151 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.87915830 |
| 152 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.86426714 |
| 153 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.84977472 |
| 154 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.84053062 |
| 155 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.84053062 |
| 156 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.84051195 |
| 157 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.83119602 |
| 158 | DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.82215166 |
| 159 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.79194105 |
| 160 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.78852707 |
| 161 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.77937059 |
| 162 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.76866802 |
| 163 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.75782311 |
| 164 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.75416725 |
| 165 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 0.74564806 |
| 166 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.73876487 |
| 167 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.73873592 |
| 168 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.72687764 |
| 169 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.72325051 |
| 170 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.72233313 |
| 171 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.71962713 |
| 172 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.71704669 |
| 173 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.70918344 |
| 174 | * CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.70635060 |
| 175 | GATA2_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.69487997 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004145_abnormal_muscle_electrophysio | 7.22759728 |
| 2 | MP0000749_muscle_degeneration | 5.23383550 |
| 3 | MP0000751_myopathy | 4.69457791 |
| 4 | MP0003646_muscle_fatigue | 4.59189771 |
| 5 | MP0002106_abnormal_muscle_physiology | 3.42459818 |
| 6 | MP0000747_muscle_weakness | 3.24927537 |
| 7 | MP0002837_dystrophic_cardiac_calcinosis | 3.22646933 |
| 8 | MP0004036_abnormal_muscle_relaxation | 3.14016420 |
| 9 | MP0000759_abnormal_skeletal_muscle | 3.02262840 |
| 10 | MP0005369_muscle_phenotype | 2.94289659 |
| 11 | MP0005620_abnormal_muscle_contractility | 2.79569093 |
| 12 | MP0000750_abnormal_muscle_regeneration | 2.62993459 |
| 13 | MP0004270_analgesia | 2.56092599 |
| 14 | MP0004087_abnormal_muscle_fiber | 2.41673555 |
| 15 | MP0004130_abnormal_muscle_cell | 2.17410105 |
| 16 | MP0002269_muscular_atrophy | 2.17198105 |
| 17 | MP0003880_abnormal_central_pattern | 2.08552644 |
| 18 | MP0002332_abnormal_exercise_endurance | 2.03190260 |
| 19 | MP0002108_abnormal_muscle_morphology | 1.83776153 |
| 20 | MP0003136_yellow_coat_color | 1.80221907 |
| 21 | MP0000733_abnormal_muscle_development | 1.75217326 |
| 22 | MP0004233_abnormal_muscle_weight | 1.66220551 |
| 23 | MP0003950_abnormal_plasma_membrane | 1.64857710 |
| 24 | MP0005330_cardiomyopathy | 1.53167989 |
| 25 | MP0010630_abnormal_cardiac_muscle | 1.51726893 |
| 26 | MP0002102_abnormal_ear_morphology | 1.50744544 |
| 27 | MP0004510_myositis | 1.49637245 |
| 28 | MP0004215_abnormal_myocardial_fiber | 1.44805367 |
| 29 | MP0004484_altered_response_of | 1.43816939 |
| 30 | MP0004142_abnormal_muscle_tone | 1.36005971 |
| 31 | MP0005266_abnormal_metabolism | 1.33299733 |
| 32 | MP0002971_abnormal_brown_adipose | 1.28158856 |
| 33 | MP0001486_abnormal_startle_reflex | 1.22046037 |
| 34 | MP0004185_abnormal_adipocyte_glucose | 1.22045478 |
| 35 | MP0001188_hyperpigmentation | 1.18938547 |
| 36 | MP0001440_abnormal_grooming_behavior | 1.17300247 |
| 37 | MP0002972_abnormal_cardiac_muscle | 1.17202999 |
| 38 | MP0003137_abnormal_impulse_conducting | 1.15639178 |
| 39 | MP0006276_abnormal_autonomic_nervous | 1.15589869 |
| 40 | MP0004134_abnormal_chest_morphology | 1.14204279 |
| 41 | MP0004742_abnormal_vestibular_system | 1.13648425 |
| 42 | MP0005645_abnormal_hypothalamus_physiol | 1.11696018 |
| 43 | MP0009745_abnormal_behavioral_response | 1.11592009 |
| 44 | MP0002734_abnormal_mechanical_nocicepti | 1.10995620 |
| 45 | MP0005409_darkened_coat_color | 1.09344661 |
| 46 | MP0009250_abnormal_appendicular_skeleto | 1.09113709 |
| 47 | MP0006036_abnormal_mitochondrial_physio | 1.08368319 |
| 48 | MP0009046_muscle_twitch | 1.04458520 |
| 49 | MP0002272_abnormal_nervous_system | 1.03871837 |
| 50 | MP0004859_abnormal_synaptic_plasticity | 1.03629071 |
| 51 | MP0004381_abnormal_hair_follicle | 1.02396470 |
| 52 | MP0005666_abnormal_adipose_tissue | 1.01076902 |
| 53 | MP0002735_abnormal_chemical_nociception | 0.99763642 |
| 54 | MP0003635_abnormal_synaptic_transmissio | 0.98197102 |
| 55 | MP0001661_extended_life_span | 0.97899927 |
| 56 | MP0002067_abnormal_sensory_capabilities | 0.97745970 |
| 57 | MP0004084_abnormal_cardiac_muscle | 0.97343966 |
| 58 | MP0000762_abnormal_tongue_morphology | 0.93722610 |
| 59 | MP0005171_absent_coat_pigmentation | 0.93578852 |
| 60 | MP0000372_irregular_coat_pigmentation | 0.93116792 |
| 61 | MP0000566_synostosis | 0.91724633 |
| 62 | MP0005451_abnormal_body_composition | 0.91348132 |
| 63 | MP0000383_abnormal_hair_follicle | 0.89719026 |
| 64 | MP0002277_abnormal_respiratory_mucosa | 0.87716488 |
| 65 | MP0005670_abnormal_white_adipose | 0.86639920 |
| 66 | MP0008775_abnormal_heart_ventricle | 0.86525055 |
| 67 | MP0002064_seizures | 0.85724176 |
| 68 | MP0009780_abnormal_chondrocyte_physiolo | 0.85094694 |
| 69 | MP0002822_catalepsy | 0.84898019 |
| 70 | MP0001299_abnormal_eye_distance/ | 0.84311451 |
| 71 | MP0000920_abnormal_myelination | 0.82528651 |
| 72 | MP0005423_abnormal_somatic_nervous | 0.82148591 |
| 73 | MP0003045_fibrosis | 0.79421722 |
| 74 | MP0001501_abnormal_sleep_pattern | 0.78303939 |
| 75 | MP0003828_pulmonary_edema | 0.78216417 |
| 76 | MP0000003_abnormal_adipose_tissue | 0.78130171 |
| 77 | MP0004147_increased_porphyrin_level | 0.77225442 |
| 78 | MP0000026_abnormal_inner_ear | 0.75231713 |
| 79 | MP0005375_adipose_tissue_phenotype | 0.74899295 |
| 80 | MP0001727_abnormal_embryo_implantation | 0.74661344 |
| 81 | MP0003879_abnormal_hair_cell | 0.73516744 |
| 82 | MP0003959_abnormal_lean_body | 0.73435759 |
| 83 | MP0002876_abnormal_thyroid_physiology | 0.73017132 |
| 84 | MP0002066_abnormal_motor_capabilities/c | 0.71271762 |
| 85 | MP0002184_abnormal_innervation | 0.70659111 |
| 86 | MP0004043_abnormal_pH_regulation | 0.70564717 |
| 87 | MP0002572_abnormal_emotion/affect_behav | 0.70182813 |
| 88 | MP0000778_abnormal_nervous_system | 0.69461277 |
| 89 | MP0001346_abnormal_lacrimal_gland | 0.68284496 |
| 90 | MP0001485_abnormal_pinna_reflex | 0.68172192 |
| 91 | MP0002063_abnormal_learning/memory/cond | 0.67921306 |
| 92 | MP0002249_abnormal_larynx_morphology | 0.67598032 |
| 93 | MP0001905_abnormal_dopamine_level | 0.66043831 |
| 94 | MP0000013_abnormal_adipose_tissue | 0.65635698 |
| 95 | MP0002638_abnormal_pupillary_reflex | 0.65120974 |
| 96 | MP0002752_abnormal_somatic_nervous | 0.65013023 |
| 97 | MP0003221_abnormal_cardiomyocyte_apopto | 0.63869473 |
| 98 | MP0006138_congestive_heart_failure | 0.63468448 |
| 99 | MP0005646_abnormal_pituitary_gland | 0.63168018 |
| 100 | MP0008569_lethality_at_weaning | 0.62727021 |
| 101 | MP0001529_abnormal_vocalization | 0.62439652 |
| 102 | MP0006292_abnormal_olfactory_placode | 0.60490219 |
| 103 | MP0001968_abnormal_touch/_nociception | 0.59182740 |
| 104 | MP0004085_abnormal_heartbeat | 0.59057529 |
| 105 | MP0001963_abnormal_hearing_physiology | 0.58594734 |
| 106 | MP0003938_abnormal_ear_development | 0.57787171 |
| 107 | MP0003385_abnormal_body_wall | 0.57414080 |
| 108 | MP0002127_abnormal_cardiovascular_syste | 0.57305491 |
| 109 | MP0005385_cardiovascular_system_phenoty | 0.56445177 |
| 110 | MP0001544_abnormal_cardiovascular_syste | 0.56445177 |
| 111 | MP0000266_abnormal_heart_morphology | 0.55917840 |
| 112 | MP0010030_abnormal_orbit_morphology | 0.49316848 |
| 113 | MP0005083_abnormal_biliary_tract | 0.48792972 |
| 114 | MP0003656_abnormal_erythrocyte_physiolo | 0.47742134 |
| 115 | * MP0002078_abnormal_glucose_homeostasis | 0.41511325 |
| 116 | MP0003806_abnormal_nucleotide_metabolis | 0.41366845 |
| 117 | MP0005166_decreased_susceptibility_to | 0.41031263 |
| 118 | MP0002114_abnormal_axial_skeleton | 0.40661476 |
| 119 | MP0005376_homeostasis/metabolism_phenot | 0.39891559 |
| 120 | MP0005167_abnormal_blood-brain_barrier | 0.37061897 |
| 121 | MP0005319_abnormal_enzyme/_coenzyme | 0.36098091 |
| 122 | MP0002896_abnormal_bone_mineralization | 0.36055954 |
| 123 | MP0005452_abnormal_adipose_tissue | 0.35981102 |
| 124 | MP0002128_abnormal_blood_circulation | 0.35742723 |
| 125 | MP0003705_abnormal_hypodermis_morpholog | 0.34188659 |
| 126 | MP0000230_abnormal_systemic_arterial | 0.32100737 |
| 127 | MP0009672_abnormal_birth_weight | 0.31497936 |
| 128 | MP0004858_abnormal_nervous_system | 0.30414002 |
| 129 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.29945354 |
| 130 | MP0003279_aneurysm | 0.27427043 |
| 131 | MP0005332_abnormal_amino_acid | 0.27063038 |
| 132 | MP0003948_abnormal_gas_homeostasis | 0.27002339 |
| 133 | MP0005535_abnormal_body_temperature | 0.26461896 |
| 134 | MP0005165_increased_susceptibility_to | 0.26359497 |
| 135 | MP0001943_abnormal_respiration | 0.25498123 |
| 136 | MP0003011_delayed_dark_adaptation | 0.24115672 |
| 137 | MP0005334_abnormal_fat_pad | 0.22011405 |
| 138 | MP0006035_abnormal_mitochondrial_morpho | 0.20412462 |
| 139 | MP0001542_abnormal_bone_strength | 0.18590581 |
| 140 | MP0002234_abnormal_pharynx_morphology | 0.16039320 |
| 141 | MP0000343_altered_response_to | 0.14604944 |
| 142 | MP0003191_abnormal_cellular_cholesterol | 0.13012070 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Muscle fiber inclusion bodies (HP:0100299) | 8.45468844 |
| 2 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 8.21943751 |
| 3 | Exercise-induced myalgia (HP:0003738) | 7.74974987 |
| 4 | Nemaline bodies (HP:0003798) | 7.70455770 |
| 5 | Muscle hypertrophy of the lower extremities (HP:0008968) | 7.25210348 |
| 6 | Exercise-induced muscle cramps (HP:0003710) | 6.72446384 |
| 7 | Distal arthrogryposis (HP:0005684) | 6.43285671 |
| 8 | Calf muscle hypertrophy (HP:0008981) | 6.31940909 |
| 9 | Round ear (HP:0100830) | 6.03999492 |
| 10 | Type 1 muscle fiber predominance (HP:0003803) | 6.02863008 |
| 11 | Myopathic facies (HP:0002058) | 5.58304547 |
| 12 | Ulnar deviation of the wrist (HP:0003049) | 5.18672034 |
| 13 | Difficulty running (HP:0009046) | 4.90072797 |
| 14 | Muscle fiber splitting (HP:0003555) | 4.75524750 |
| 15 | Calcaneovalgus deformity (HP:0001848) | 4.63445571 |
| 16 | Absent phalangeal crease (HP:0006109) | 4.55964931 |
| 17 | Abnormality of the calf musculature (HP:0001430) | 4.31827883 |
| 18 | Muscle stiffness (HP:0003552) | 4.27944356 |
| 19 | Deformed tarsal bones (HP:0008119) | 4.24633193 |
| 20 | EMG: myopathic abnormalities (HP:0003458) | 4.18523092 |
| 21 | Hyporeflexia of lower limbs (HP:0002600) | 4.15496815 |
| 22 | Abnormal finger flexion creases (HP:0006143) | 3.84441501 |
| 23 | Malignant hyperthermia (HP:0002047) | 3.82573664 |
| 24 | Myoglobinuria (HP:0002913) | 3.76186331 |
| 25 | Hyperkalemia (HP:0002153) | 3.67802262 |
| 26 | Myotonia (HP:0002486) | 3.60436624 |
| 27 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.45248337 |
| 28 | Subaortic stenosis (HP:0001682) | 3.45248337 |
| 29 | Increased connective tissue (HP:0009025) | 3.22780314 |
| 30 | Rhabdomyolysis (HP:0003201) | 3.19207066 |
| 31 | Fetal akinesia sequence (HP:0001989) | 3.17671605 |
| 32 | Neck muscle weakness (HP:0000467) | 3.09539857 |
| 33 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.02309908 |
| 34 | Abnormality of the neuromuscular junction (HP:0003398) | 2.93205949 |
| 35 | Fatigable weakness (HP:0003473) | 2.93205949 |
| 36 | Nonprogressive disorder (HP:0003680) | 2.86511647 |
| 37 | Muscle fiber atrophy (HP:0100295) | 2.84002469 |
| 38 | Sudden death (HP:0001699) | 2.75942741 |
| 39 | Rimmed vacuoles (HP:0003805) | 2.74149420 |
| 40 | Increased variability in muscle fiber diameter (HP:0003557) | 2.68665036 |
| 41 | Bundle branch block (HP:0011710) | 2.65144754 |
| 42 | Shoulder girdle muscle weakness (HP:0003547) | 2.60949022 |
| 43 | Difficulty climbing stairs (HP:0003551) | 2.59534604 |
| 44 | Distal lower limb muscle weakness (HP:0009053) | 2.55622916 |
| 45 | Limb-girdle muscle atrophy (HP:0003797) | 2.53518281 |
| 46 | Paralysis (HP:0003470) | 2.50880568 |
| 47 | Abnormality of the musculature of the pelvis (HP:0001469) | 2.50865475 |
| 48 | Abnormality of the hip-girdle musculature (HP:0001445) | 2.50865475 |
| 49 | Areflexia of lower limbs (HP:0002522) | 2.48315565 |
| 50 | Hypoplastic ischia (HP:0003175) | 2.48070311 |
| 51 | Pelvic girdle muscle weakness (HP:0003749) | 2.47427893 |
| 52 | Bulbar palsy (HP:0001283) | 2.42632975 |
| 53 | Focal motor seizures (HP:0011153) | 2.42618708 |
| 54 | Gowers sign (HP:0003391) | 2.31250195 |
| 55 | Weak cry (HP:0001612) | 2.28643384 |
| 56 | Abnormality of the calcaneus (HP:0008364) | 2.26227275 |
| 57 | Dilated cardiomyopathy (HP:0001644) | 2.22581689 |
| 58 | Frequent falls (HP:0002359) | 2.18376205 |
| 59 | Muscular dystrophy (HP:0003560) | 2.16886504 |
| 60 | Abnormality of the ischium (HP:0003174) | 2.15648255 |
| 61 | Generalized muscle weakness (HP:0003324) | 2.14570063 |
| 62 | Popliteal pterygium (HP:0009756) | 2.12266762 |
| 63 | Slender build (HP:0001533) | 2.11392441 |
| 64 | Distal lower limb amyotrophy (HP:0008944) | 2.11367503 |
| 65 | Easy fatigability (HP:0003388) | 2.08409363 |
| 66 | Lipoatrophy (HP:0100578) | 2.07598248 |
| 67 | Progressive muscle weakness (HP:0003323) | 2.02980172 |
| 68 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 2.00861687 |
| 69 | Abnormality of potassium homeostasis (HP:0011042) | 1.93891192 |
| 70 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.93670204 |
| 71 | Parakeratosis (HP:0001036) | 1.91516636 |
| 72 | EMG: neuropathic changes (HP:0003445) | 1.87591704 |
| 73 | Broad-based gait (HP:0002136) | 1.85656636 |
| 74 | Asymmetric septal hypertrophy (HP:0001670) | 1.83800992 |
| 75 | Scapular winging (HP:0003691) | 1.80527345 |
| 76 | Type 2 muscle fiber atrophy (HP:0003554) | 1.79855128 |
| 77 | Facial diplegia (HP:0001349) | 1.77756545 |
| 78 | Ventricular tachycardia (HP:0004756) | 1.74792459 |
| 79 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.74657797 |
| 80 | Ulnar deviation of finger (HP:0009465) | 1.74316259 |
| 81 | Hip contracture (HP:0003273) | 1.73656805 |
| 82 | Heart block (HP:0012722) | 1.71788275 |
| 83 | Proximal amyotrophy (HP:0007126) | 1.71636857 |
| 84 | Abnormality of the foot musculature (HP:0001436) | 1.71438128 |
| 85 | Aplasia of the musculature (HP:0100854) | 1.71284186 |
| 86 | Acute necrotizing encephalopathy (HP:0006965) | 1.69868300 |
| 87 | Thin ribs (HP:0000883) | 1.69832419 |
| 88 | Pterygium (HP:0001059) | 1.67680527 |
| 89 | Akinesia (HP:0002304) | 1.65692616 |
| 90 | Limb-girdle muscle weakness (HP:0003325) | 1.63407005 |
| 91 | Ventricular arrhythmia (HP:0004308) | 1.63065170 |
| 92 | Fibular aplasia (HP:0002990) | 1.63007978 |
| 93 | Abnormal atrioventricular conduction (HP:0005150) | 1.62442140 |
| 94 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.61702932 |
| 95 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 1.60854490 |
| 96 | Foot dorsiflexor weakness (HP:0009027) | 1.60130690 |
| 97 | Metatarsus adductus (HP:0001840) | 1.59714212 |
| 98 | Nasal speech (HP:0001611) | 1.57468559 |
| 99 | Bell-shaped thorax (HP:0001591) | 1.57280010 |
| 100 | Spinal rigidity (HP:0003306) | 1.54103039 |
| 101 | Limited hip movement (HP:0008800) | 1.53846352 |
| 102 | Amniotic constriction ring (HP:0009775) | 1.53846177 |
| 103 | Abnormality of placental membranes (HP:0011409) | 1.53846177 |
| 104 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.53351083 |
| 105 | Absent/shortened dynein arms (HP:0200106) | 1.53167325 |
| 106 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.53167325 |
| 107 | Exercise intolerance (HP:0003546) | 1.52034011 |
| 108 | Atonic seizures (HP:0010819) | 1.52001991 |
| 109 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.48975482 |
| 110 | Febrile seizures (HP:0002373) | 1.47997116 |
| 111 | Long clavicles (HP:0000890) | 1.47819286 |
| 112 | Hypoplastic heart (HP:0001961) | 1.47410821 |
| 113 | Hypokalemia (HP:0002900) | 1.47116582 |
| 114 | Ulnar deviation of the hand or of fingers of the hand (HP:0001193) | 1.46873065 |
| 115 | Waddling gait (HP:0002515) | 1.46326259 |
| 116 | Lower limb amyotrophy (HP:0007210) | 1.46239059 |
| 117 | Ragged-red muscle fibers (HP:0003200) | 1.38542679 |
| 118 | Short palpebral fissure (HP:0012745) | 1.31822409 |
| 119 | Cystic hygroma (HP:0000476) | 1.31417638 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | OBSCN | 6.16999065 |
| 2 | PHKG2 | 5.02180566 |
| 3 | PHKG1 | 5.02180566 |
| 4 | TTN | 3.77439276 |
| 5 | NME1 | 3.71347426 |
| 6 | PIK3CG | 3.34186003 |
| 7 | CASK | 2.99972593 |
| 8 | MUSK | 2.54353033 |
| 9 | TNIK | 2.48182471 |
| 10 | BLK | 2.29089343 |
| 11 | PIK3CA | 1.88174025 |
| 12 | MAP2K4 | 1.73561528 |
| 13 | MAP3K7 | 1.70081249 |
| 14 | PKN1 | 1.66532341 |
| 15 | MAPK12 | 1.57997143 |
| 16 | OXSR1 | 1.56850703 |
| 17 | PINK1 | 1.46156903 |
| 18 | DMPK | 1.42511095 |
| 19 | PNCK | 1.39662007 |
| 20 | INSRR | 1.38643826 |
| 21 | MAP2K3 | 1.36320652 |
| 22 | STK39 | 1.36224428 |
| 23 | EPHB1 | 1.36023180 |
| 24 | MAPKAPK3 | 1.35806026 |
| 25 | GRK7 | 1.30523449 |
| 26 | MKNK2 | 1.28270397 |
| 27 | LIMK1 | 1.24801172 |
| 28 | CCNB1 | 1.21759225 |
| 29 | PRKAA2 | 1.09205190 |
| 30 | EEF2K | 0.91882763 |
| 31 | MAP2K7 | 0.90913937 |
| 32 | EPHA4 | 0.90728982 |
| 33 | MAPK13 | 0.84261153 |
| 34 | BCR | 0.83078465 |
| 35 | NTRK3 | 0.81386565 |
| 36 | NEK1 | 0.80646252 |
| 37 | FGR | 0.77657492 |
| 38 | CDK3 | 0.77096895 |
| 39 | MAP2K6 | 0.75994015 |
| 40 | CAMK1G | 0.75305236 |
| 41 | CAMK2G | 0.72758021 |
| 42 | CAMK2A | 0.69877995 |
| 43 | EIF2AK2 | 0.69735361 |
| 44 | PRKG1 | 0.69720603 |
| 45 | MAP3K4 | 0.69350405 |
| 46 | DYRK1B | 0.69201762 |
| 47 | NEK6 | 0.67526268 |
| 48 | GRK1 | 0.67444890 |
| 49 | MOS | 0.67101629 |
| 50 | MAP3K12 | 0.66111943 |
| 51 | BMPR2 | 0.63996369 |
| 52 | ADRBK2 | 0.63751580 |
| 53 | SGK1 | 0.62544985 |
| 54 | MAP2K1 | 0.62398415 |
| 55 | BCKDK | 0.61882304 |
| 56 | CAMK2D | 0.59976013 |
| 57 | MARK1 | 0.58237857 |
| 58 | MAPK11 | 0.57452185 |
| 59 | NEK9 | 0.56060768 |
| 60 | PDK2 | 0.55892936 |
| 61 | MAP3K6 | 0.55766304 |
| 62 | SIK2 | 0.54754931 |
| 63 | CAMK2B | 0.54671512 |
| 64 | ZAK | 0.53811934 |
| 65 | PRKAA1 | 0.53246809 |
| 66 | GRK5 | 0.53058242 |
| 67 | PTK2B | 0.52326493 |
| 68 | PRKCE | 0.52233708 |
| 69 | TRPM7 | 0.51823534 |
| 70 | PLK2 | 0.51734505 |
| 71 | MAPK15 | 0.51603732 |
| 72 | ROCK2 | 0.50864084 |
| 73 | IRAK4 | 0.48738751 |
| 74 | TRIB3 | 0.48448150 |
| 75 | PRKACB | 0.48444845 |
| 76 | PRKACA | 0.48233574 |
| 77 | MAPK4 | 0.47897158 |
| 78 | CAMK4 | 0.47624293 |
| 79 | PAK6 | 0.47614144 |
| 80 | WNK1 | 0.47497609 |
| 81 | MAPK7 | 0.46438132 |
| 82 | IRAK1 | 0.46060398 |
| 83 | SIK3 | 0.45739383 |
| 84 | IRAK3 | 0.44638704 |
| 85 | PDK3 | 0.44406451 |
| 86 | PDK4 | 0.44406451 |
| 87 | MARK2 | 0.43412886 |
| 88 | AKT2 | 0.43402749 |
| 89 | SGK3 | 0.43347433 |
| 90 | RIPK1 | 0.42943766 |
| 91 | WNK4 | 0.42148970 |
| 92 | BMPR1B | 0.42121422 |
| 93 | MAP3K13 | 0.41030717 |
| 94 | STK16 | 0.40127843 |
| 95 | CDK19 | 0.39368853 |
| 96 | ADRBK1 | 0.38755530 |
| 97 | MKNK1 | 0.38476481 |
| 98 | ICK | 0.37897593 |
| 99 | EPHB2 | 0.36953147 |
| 100 | SIK1 | 0.36770159 |
| 101 | TIE1 | 0.36455745 |
| 102 | IRAK2 | 0.36164070 |
| 103 | FER | 0.35813149 |
| 104 | LATS2 | 0.35669886 |
| 105 | PRKCQ | 0.34915786 |
| 106 | STK11 | 0.34739742 |
| 107 | CDK5 | 0.34055650 |
| 108 | RIPK4 | 0.33864526 |
| 109 | NTRK2 | 0.33723478 |
| 110 | TNK2 | 0.33362680 |
| 111 | TBK1 | 0.32996134 |
| 112 | KSR2 | 0.32839262 |
| 113 | ERBB3 | 0.32018932 |
| 114 | MAP3K14 | 0.31250126 |
| 115 | PAK3 | 0.30635573 |
| 116 | SGK2 | 0.29558075 |
| 117 | CAMK1 | 0.28621393 |
| 118 | DYRK1A | 0.28288459 |
| 119 | RPS6KA3 | 0.27609167 |
| 120 | ROCK1 | 0.27524069 |
| 121 | FES | 0.26429989 |
| 122 | MAPK10 | 0.24205947 |
| 123 | MAP3K1 | 0.23120794 |
| 124 | RPS6KB1 | 0.22311541 |
| 125 | PDPK1 | 0.21883090 |
| 126 | TAOK2 | 0.21770059 |
| 127 | DAPK2 | 0.20985892 |
| 128 | MAP3K10 | 0.16776518 |
| 129 | CDK8 | 0.16334000 |
| 130 | RPS6KA1 | 0.15904943 |
| 131 | PDK1 | 0.14481149 |
| 132 | ARAF | 0.13794705 |
| 133 | MAP3K5 | 0.13104971 |
| 134 | RPS6KB2 | 0.12471692 |
| 135 | MAP3K11 | 0.12090268 |
| 136 | ZAP70 | 0.11928189 |
| 137 | MTOR | 0.11012059 |
| 138 | PRKACG | 0.10350746 |
| 139 | RPS6KL1 | 0.09587552 |
| 140 | RPS6KC1 | 0.09587552 |
| 141 | PRKD1 | 0.08199438 |
| 142 | TGFBR2 | 0.08065019 |
| 143 | SGK223 | 0.07463623 |
| 144 | SGK494 | 0.07463623 |
| 145 | RPS6KA6 | 0.05955489 |
| 146 | MARK3 | 0.04675385 |
| 147 | ILK | 0.03286464 |
| 148 | MAPK8 | 0.03235650 |
| 149 | RPS6KA2 | 0.02699588 |
| 150 | RAF1 | 0.02629096 |
| 151 | CSNK1D | 0.02567171 |
| 152 | PRPF4B | 0.02527851 |
| 153 | PAK1 | 0.01725692 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 3.55178524 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.52611071 |
| 3 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 3.22400341 |
| 4 | * Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 3.21498735 |
| 5 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 2.96196027 |
| 6 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.95275858 |
| 7 | Calcium signaling pathway_Homo sapiens_hsa04020 | 2.41006664 |
| 8 | Alzheimers disease_Homo sapiens_hsa05010 | 2.39062467 |
| 9 | Nicotine addiction_Homo sapiens_hsa05033 | 2.35632858 |
| 10 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 2.26619851 |
| 11 | Parkinsons disease_Homo sapiens_hsa05012 | 2.24047733 |
| 12 | Carbon metabolism_Homo sapiens_hsa01200 | 2.18646876 |
| 13 | * Oxytocin signaling pathway_Homo sapiens_hsa04921 | 2.02489185 |
| 14 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.94173322 |
| 15 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.91902772 |
| 16 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.79339952 |
| 17 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.76085686 |
| 18 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.73856900 |
| 19 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.68383271 |
| 20 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.64086567 |
| 21 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.60677270 |
| 22 | * Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.55795174 |
| 23 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.50190825 |
| 24 | GABAergic synapse_Homo sapiens_hsa04727 | 1.48115828 |
| 25 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.46316154 |
| 26 | Renin secretion_Homo sapiens_hsa04924 | 1.44560718 |
| 27 | Phototransduction_Homo sapiens_hsa04744 | 1.44108907 |
| 28 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.42887663 |
| 29 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.42730180 |
| 30 | Morphine addiction_Homo sapiens_hsa05032 | 1.37816077 |
| 31 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.35422418 |
| 32 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.34481686 |
| 33 | Taste transduction_Homo sapiens_hsa04742 | 1.34248299 |
| 34 | Huntingtons disease_Homo sapiens_hsa05016 | 1.33400337 |
| 35 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.32198202 |
| 36 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.28800226 |
| 37 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.27276606 |
| 38 | Axon guidance_Homo sapiens_hsa04360 | 1.26678319 |
| 39 | Circadian entrainment_Homo sapiens_hsa04713 | 1.21690340 |
| 40 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.20951842 |
| 41 | * Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.19340100 |
| 42 | Salivary secretion_Homo sapiens_hsa04970 | 1.17643334 |
| 43 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.16497293 |
| 44 | Long-term depression_Homo sapiens_hsa04730 | 1.12790160 |
| 45 | Insulin secretion_Homo sapiens_hsa04911 | 1.09003594 |
| 46 | Tight junction_Homo sapiens_hsa04530 | 1.08844635 |
| 47 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.07344815 |
| 48 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.07282219 |
| 49 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.06868811 |
| 50 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.00930480 |
| 51 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.98679806 |
| 52 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.97720774 |
| 53 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.97712169 |
| 54 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.94181901 |
| 55 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.92278212 |
| 56 | * Circadian rhythm_Homo sapiens_hsa04710 | 0.90554747 |
| 57 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.89479205 |
| 58 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.85081029 |
| 59 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.83920127 |
| 60 | Galactose metabolism_Homo sapiens_hsa00052 | 0.82916975 |
| 61 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.82644602 |
| 62 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.82570519 |
| 63 | * Insulin signaling pathway_Homo sapiens_hsa04910 | 0.81604065 |
| 64 | Melanogenesis_Homo sapiens_hsa04916 | 0.77680125 |
| 65 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.77301296 |
| 66 | Olfactory transduction_Homo sapiens_hsa04740 | 0.77278736 |
| 67 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.74525932 |
| 68 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.73552997 |
| 69 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.73025800 |
| 70 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.72465172 |
| 71 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.72110918 |
| 72 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.71469588 |
| 73 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.67648772 |
| 74 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.67438830 |
| 75 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.67250293 |
| 76 | Long-term potentiation_Homo sapiens_hsa04720 | 0.67068286 |
| 77 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.65015441 |
| 78 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.62828030 |
| 79 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.60689644 |
| 80 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.58403601 |
| 81 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.57925527 |
| 82 | * Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.56681050 |
| 83 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.55742671 |
| 84 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.54852112 |
| 85 | * AMPK signaling pathway_Homo sapiens_hsa04152 | 0.54595487 |
| 86 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.54496429 |
| 87 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.53824522 |
| 88 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.53381076 |
| 89 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.52575134 |
| 90 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.51924482 |
| 91 | Focal adhesion_Homo sapiens_hsa04510 | 0.51862485 |
| 92 | Histidine metabolism_Homo sapiens_hsa00340 | 0.51226273 |
| 93 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.50444888 |
| 94 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.49845380 |
| 95 | * Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.48690251 |
| 96 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.48655255 |
| 97 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.48284205 |
| 98 | Viral myocarditis_Homo sapiens_hsa05416 | 0.47198878 |
| 99 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.46691246 |
| 100 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.46515026 |
| 101 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.44377693 |
| 102 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.43315131 |
| 103 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.42924841 |
| 104 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.42468070 |
| 105 | * Insulin resistance_Homo sapiens_hsa04931 | 0.40828751 |
| 106 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.40220224 |
| 107 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.39856889 |
| 108 | * FoxO signaling pathway_Homo sapiens_hsa04068 | 0.39687633 |
| 109 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.39494039 |
| 110 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.39114416 |
| 111 | Peroxisome_Homo sapiens_hsa04146 | 0.37693114 |
| 112 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.36812024 |
| 113 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.36222995 |
| 114 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.35587446 |
| 115 | Cocaine addiction_Homo sapiens_hsa05030 | 0.32331749 |
| 116 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.32304858 |
| 117 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.31116412 |
| 118 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.31108929 |
| 119 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.29933285 |
| 120 | Phagosome_Homo sapiens_hsa04145 | 0.29857747 |
| 121 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.29613423 |
| 122 | Metabolic pathways_Homo sapiens_hsa01100 | 0.29437798 |
| 123 | Amoebiasis_Homo sapiens_hsa05146 | 0.29396394 |
| 124 | Gap junction_Homo sapiens_hsa04540 | 0.28970718 |
| 125 | Lysine degradation_Homo sapiens_hsa00310 | 0.26798657 |
| 126 | Platelet activation_Homo sapiens_hsa04611 | 0.24891429 |
| 127 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.24089542 |
| 128 | Glioma_Homo sapiens_hsa05214 | 0.23630076 |
| 129 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.22820800 |
| 130 | * Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.22251892 |
| 131 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.21607104 |
| 132 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.20720762 |
| 133 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.19223881 |
| 134 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.18727461 |
| 135 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.18628091 |
| 136 | Adherens junction_Homo sapiens_hsa04520 | 0.18546907 |
| 137 | Purine metabolism_Homo sapiens_hsa00230 | 0.16907368 |
| 138 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.11401059 |
| 139 | Sulfur relay system_Homo sapiens_hsa04122 | 0.10823105 |
| 140 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.09494795 |
| 141 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.08107587 |

